Home›Companies›Healthcare›Treatment Technologies & Insights

Treatment Technologies & Insights, Inc.

Updated Oct 29, 2026·Latest SEC filing Feb 21, 2025·Suggest an edit

About Treatment Technologies & Insights

Treatment Technologies & Insights is a private company based in El Segundo, California. It has reported $5,999,998 raised in two offerings on Form D since September 2022. Its chief executive is Matthew Lashey.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 11, 2024Feb 21, 2025$4,500,000of $10.0M target1$4.5MEquityRule 506(b)Form D ↗
Jul 29, 2022Sep 2, 2022$1,499,998fully sold3$499KEquityRule 506(b)Form D ↗
Total, two offerings$5,999,998

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Treatment Technologies & Insights's Form D filed Feb 21, 2025.

RB
Robert Badal
Executive officer and director
Also a director at Commons Clinic.
JG
ML
Matthew Lashey
Chief Executive Officer and director

Sources

  1. SECTreatment Technologies & Insights, Inc. filing history